European Society of Gene & Cell Therapy (ESGCT) 2025

Symcel will exhibit at the European Society of Gene & Cell Therapy (ESGCT), 7–10 October 2025, Seville.

The meeting brings together researchers, clinicians, and industry to exchange the latest progress in cell and gene therapy. Visit us at Booth A07 to discover how the calScreener+™ is redefining sterility testing for advanced therapies.

The calScreener+™ biocalorimeter system from Symcel represents a paradigm shift in growth-based sterility testing — reducing detection timelines to under three days.

This means a reduction of over 70% in incubation time compared to compendial methods, while also minimizing hands-on time and providing real-time insights through continuous readouts indicating the presence or absence of contamination.

For cell and gene therapy producers, this breakthrough is a potential game-changer. It allows for mitigation of contamination risks, to eliminate the issue of product matrices, to simplify manufacturing processes, and to slash time-to-market.

Visit our applications page to learn more about  rapid sterility testing of cell and gene therapy products.

Contact us to schedule a meeting during the conference.